Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Brain : a Journal of Neurology
|
August 31, 2024
Brain-penetrant complement inhibition mitigates neurodegeneration in an Alzheimer's disease mouse model
Wioleta M Zelek, Ryan J Bevan, Jacqui Nimmo, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
November 25, 2003
Deficiency of the complement regulator CD59a enhances disease severity, demyelination and axonal injury in murine acute experimental allergic encephalomyelitis
Richard James Mead, James William Neal, Mark Raymond Griffiths, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society
|
February 3, 2026
Complement in brain and eye disease: shared mechanisms, convergent pathologies, and common therapeutic opportunities
Nikoleta Daskoulidou, Jacqui Nimmo, Matthew Bright, et al.
Molecular Immunology
|
October 17, 2009
Complement inhibition accelerates regeneration in a model of peripheral nerve injury
Valeria Ramaglia, Martijn Rudolf Tannemaat, Maryla de Kok, et al.
Journal of Alzheimer'S Disease : JAD
|
August 29, 2016
Complement Biomarkers as Predictors of Disease Progression in Alzheimer's Disease
Svetlana Hakobyan, Katharine Harding, Mohammed Aiyaz, et al.
Brain : a Journal of Neurology
|
April 28, 2010
Complement regulator factor H as a serum biomarker of multiple sclerosis disease state
Gillian Ingram, Svetlana Hakobyan, Claire L Hirst, et al.
Brain Pathology (Zurich, Switzerland)
|
July 15, 2017
Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosis
Sam Loveless, James W Neal, Owain W Howell, et al.
Journal of Neuroinflammation
|
July 21, 2023
Alzheimer's disease-associated complement gene variants influence plasma complement protein levels
Aurora Veteleanu, Joshua Stevenson-Hoare, Samuel Keat, et al.
Brain Pathology (Zurich, Switzerland)
|
December 23, 2022
Dendritic spine loss in epileptogenic Type II focal cortical dysplasia: Role of enhanced classical complement pathway activation
Laura Rossini, Dalia De Santis, Erica Cecchini, et al.
Brain, Behavior, and Immunity
|
March 20, 2025
The schizophrenia-associated gene CSMD1 encodes a complement classical pathway inhibitor predominantly expressed by astrocytes and at synapses in mice and humans
Robert A J Byrne, Jacqui Nimmo, Megan Torvell, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Brain : a Journal of Neurology
|
August 31, 2024
Brain-penetrant complement inhibition mitigates neurodegeneration in an Alzheimer's disease mouse model
Wioleta M Zelek, Ryan J Bevan, Jacqui Nimmo, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
November 25, 2003
Deficiency of the complement regulator CD59a enhances disease severity, demyelination and axonal injury in murine acute experimental allergic encephalomyelitis
Richard James Mead, James William Neal, Mark Raymond Griffiths, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society
|
February 3, 2026
Complement in brain and eye disease: shared mechanisms, convergent pathologies, and common therapeutic opportunities
Nikoleta Daskoulidou, Jacqui Nimmo, Matthew Bright, et al.
Molecular Immunology
|
October 17, 2009
Complement inhibition accelerates regeneration in a model of peripheral nerve injury
Valeria Ramaglia, Martijn Rudolf Tannemaat, Maryla de Kok, et al.
Journal of Alzheimer'S Disease : JAD
|
August 29, 2016
Complement Biomarkers as Predictors of Disease Progression in Alzheimer's Disease
Svetlana Hakobyan, Katharine Harding, Mohammed Aiyaz, et al.
Brain : a Journal of Neurology
|
April 28, 2010
Complement regulator factor H as a serum biomarker of multiple sclerosis disease state
Gillian Ingram, Svetlana Hakobyan, Claire L Hirst, et al.
Brain Pathology (Zurich, Switzerland)
|
July 15, 2017
Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosis
Sam Loveless, James W Neal, Owain W Howell, et al.
Journal of Neuroinflammation
|
July 21, 2023
Alzheimer's disease-associated complement gene variants influence plasma complement protein levels
Aurora Veteleanu, Joshua Stevenson-Hoare, Samuel Keat, et al.
Brain Pathology (Zurich, Switzerland)
|
December 23, 2022
Dendritic spine loss in epileptogenic Type II focal cortical dysplasia: Role of enhanced classical complement pathway activation
Laura Rossini, Dalia De Santis, Erica Cecchini, et al.
Brain, Behavior, and Immunity
|
March 20, 2025
The schizophrenia-associated gene CSMD1 encodes a complement classical pathway inhibitor predominantly expressed by astrocytes and at synapses in mice and humans
Robert A J Byrne, Jacqui Nimmo, Megan Torvell, et al.
Page
of 3